Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 2 Solid Tumors 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Mesothelioma 1 Medulloblastoma 1 Hepatoblastoma 1 Head and Neck Carcinoma of Unknown Primary 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Bone Metastases 1 Advanced Solid Tumor 1

Interventions

Pemetrexed 40 Cisplatin 35 pembrolizumab 21 Nivolumab 17 Carboplatin 16 Ipilimumab 13 Gemcitabine 10 Cyclophosphamide 9 fludarabine 6 durvalumab 6 Bevacizumab 6 Radiotherapy, Intensity-Modulated 4 LMB-100 4 Drug Therapy 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 spartalizumab 3 olaparib 3 niraparib 3 atezolizumab 3 anetumab ravtansine 3 amatuximab 3 Vinorelbine 3 Paclitaxel 3 Oxaliplatin 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Radiation × Other solid neoplasm × Clear all

NCT01604005 2018-01-29

PIT

The Christie NHS Foundation Trust

Phase 3 Terminated

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡